1.	Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study. Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CSOM230B2412, NCT01794793
2.	Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Under 22 at diagnosis Sponsor: NCI, Other Protocol IDs: CDR0000467191, COG-ARAR0332, ARAR0332, NCT00304070
3.	Efficacy of Adjuvant Mitotane Treatment (ADIUVO) Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: EudraCT 2007-007262-38, NCT00777244
4.	A Clinical Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BBI608-201, NCT01325441
5.	Interleukin 13 PE for Adults With Advanced Cancers Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 130046, 13-C-0046, NCT01766635
6.	External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: IOSI-RO0402, RO0402, NCT00637637
7.	Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients Phase: Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: EudraCT 2008-000759-91, NCT00786110
8.	Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer Phase: Phase II Type: Treatment Status: Active Age: 6 months and over Sponsor: Other Protocol IDs: CDR0000066485, BC-AD-2, NCT00003453
9.	A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours Phase: Phase II Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: I206, NCT01396408
10.	A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 11/106, U1111-1132-5574, NCT01676428
11.	Surgery and Heated Chemotherapy for Adrenocortical Carcinoma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 130114, 13-C-0114, NCT01833832
12.	Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-03112, 050909, U01CA132194, CINJ-050801, 050801, 0220080281, NCT00813423
13.	Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 3 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000663520, COG-ADVL0911, ADVL0911, NCT01048892
14.	Intraperitoneal Radioimmunotherapy With 131I-8H9 for Patients With Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 and over Sponsor: Other Protocol IDs: 09-090, NCT01099644
15.	Evaluation of Side Effects of Mitotane Phase: No phase specified Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: Wue-ACC-Mitotane, NCT00568139
16.	Adrenal Tumors - Pathogenesis and Therapy Phase: No phase specified Type: Diagnostic, Treatment Status: Active Age: Any age Sponsor: Other Protocol IDs: Wue-Adrenal-Tumors-92/2002, NCT00669266
17.	Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010/297, NCT01246739